Dr. Simon Khagi, MD

Dr. Khagi practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Khagi's NPI, 1710121165, was assigned on April 29, 2009. Dr. Khagi graduated from UMKC School of Medicine in 2009. Dr. Khagi holds California license 187017.

Dr. Khagi's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Khagi also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Khagi's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. Dr. Khagi is also affiliated with UCI Health - Orange. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Khagi to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khagi practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khagi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khagi is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Khagi's licenses on file in 4 states: California, New Hampshire, North Carolina and Massachusetts.

Dmand AI lists lung cancer and multiple myeloma among the conditions Dr. Khagi treats.

CMS data shows 1,082 Medicare services from Dr. Khagi across 7 procedure codes in 2024, for 89 Medicare patients. Medicare paid $71,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Khagi in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khagi's median patient age at 72, with 45% women.

In 2024, Dr. Khagi wrote 776 Medicare Part D claims for 77 patients. 85% of them were for generic drugs. CMS names the drug for 565 of them, across 22 drugs with 11 or more claims each, at $1,065,784 in total drug cost. In 2023, CMS named 385 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Khagi for performance year 2024, reported as part of a group. Dr. Khagi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khagi as offering telehealth.

Dmand AI links 29 papers to Dr. Khagi, published from 2013 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Glioblastoma, Brain Neoplasms and Neuroendocrine Tumors. Dr. Khagi has published most often in JOP. Dr. Khagi's most frequent co-authors are Matthew G. Ewend, Samuel A. Goldlust, MD and Steven R. Abram, MD.

Dmand AI links Dr. Khagi to 12 clinical trials, 7 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Glioblastoma, Brain Neoplasms and Gliosarcoma. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 124 general payments to Dr. Khagi from 19 drug and device companies from 2020 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 31% of the total. Novocure Inc. paid the most, $80,567.

Dmand AI lists 8 awards for Dr. Khagi, most recently Healthcare Hero in 2025.

Dr. Khagi graduated from UMKC School of Medicine in 2009. Dr. Khagi is a member of Alliance for Clinical Trials in Oncology, AACR, AAPL, ACP, ASCO and ASH.

Dr. Khagi is in network with 9 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.